The ALK inhibitor ASP3026 eradicates NPM-ALK+ T-cell anaplastic large-cell lymphoma <i>in vitro</i> and in a systemic xenograft lymphoma modelSuraj K. George, Hesham M. Amin|Oncotarget|2014Cited by 28